arrow
S

Santo Raffaele Mercuri

IRCCS Ospedale San Raffaele
H指数:22
被引数:2,233

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study

非节段性白癜风患者外用鲁索利替尼的实世界有效性:一项860例患者多中心研究中关于复色、心理健康和生活质量结局的研究

2026-08-170
PRE
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)

Dupilumab或Upadacitinib在轻至重度特应性皮炎中的纵向反应轨迹:一项多中心真实世界研究:IL-AD(意大利特应性皮炎研究)

2026-05-290
OAAI
Combination therapies for hidradenitis suppurativa: Narrative review of current strategies and emerging perspectives

Hidradenitis suppurativa的组合疗法:当前策略与新兴视角的叙述性综述

2026-05-200
PRE
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes—IL PSO (Italian Landscape Psoriasis)

德卡巴替尼在银屑病中的短期有效性与安全性:一项多中心真实世界研究,重点关注头皮特定结局——IL PSO(意大利银屑病全景研究)

2026-03-160
OAAI
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study)

Tirbanibulin 1%在温暖季节(SUMM-AK研究)中679例光线性角化病患者中的真实世界应用

2025-11-260
OAAI
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option

长期系统性使用利福平和克林霉素治疗表皮生长因子受体抑制剂相关的痤疮样和黏膜皮肤疹:一种有效的治疗选择

2025-10-290
PRE
Effectiveness and safety of upadacitinib in patients with moderate-to-severe atopic dermatitis and prior inefficacy of T helper 2 biologics: a propensity score-matched study

乌帕替尼在伴有中重度特应性皮炎且既往对Th2生物制剂无效患者中的有效性与安全性:一项倾向性评分匹配研究

2025-08-010
PRE
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)

度普利尤单抗治疗中重度银屑病的强应答者特征:一项短期真实世界观察-IL PSO(意大利银屑病全景研究)

2025-05-150
OAAI
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)

银屑病患者中性别对Bimekizumab应答的影响:IL PSO(意大利银屑病景观)真实世界多中心回顾性研究的结果

2025-05-130
OA
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study

Dupilumab治疗特应性皮炎的五年药物生存率:意大利特应性皮炎真实世界研究

2025-04-170
PRE
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis)
2025-04-010
OAAI
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study

肛直肠黑色素瘤:一项多中心研究中的临床病理特征,一种罕见且侵袭性的恶性肿瘤

2025-03-180
PRE
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience

青少年和年轻人的黑色素瘤 (AYAs): 意大利的多中心回顾性经验

2024-10-281
OAAI